Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1993-2-23
|
pubmed:abstractText |
We administered the Karolinska Scales of Personality to 225 healthy subjects in Spain selected from a group of 925 individuals previously phenotyped with regard to their capacity to hydroxylate debrisoquine. A significant relationship was found between the scores in as many as 4 of the 15 subscales (psychic anxiety, psychasthenia, inhibition of aggression and socialization) and the debrisoquine hydroxylation capacity. Poor metabolizers were more anxiety-prone and less successfully socialized than extensive metabolizers of debrisoquine. This and a previous study among subjects in Sweden suggest that there may be a relationship between personality and the activity of the enzyme hydroxylating debrisoquine (cytochrome P4502D6). This polymorphic enzyme may have an endogenous neuroactive substrate or product, such as a biogenic neurotransmitter amine.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0001-690X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
87
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
23-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8424321-Adolescent,
pubmed-meshheading:8424321-Adult,
pubmed-meshheading:8424321-Analysis of Variance,
pubmed-meshheading:8424321-Cytochrome P-450 CYP2D6,
pubmed-meshheading:8424321-Cytochrome P-450 Enzyme System,
pubmed-meshheading:8424321-Debrisoquin,
pubmed-meshheading:8424321-Female,
pubmed-meshheading:8424321-Humans,
pubmed-meshheading:8424321-Hydroxylation,
pubmed-meshheading:8424321-Male,
pubmed-meshheading:8424321-Mixed Function Oxygenases,
pubmed-meshheading:8424321-Personality,
pubmed-meshheading:8424321-Personality Inventory,
pubmed-meshheading:8424321-Phenotype
|
pubmed:year |
1993
|
pubmed:articleTitle |
Relationship between personality and debrisoquine hydroxylation capacity. Suggestion of an endogenous neuroactive substrate or product of the cytochrome P4502D6.
|
pubmed:affiliation |
Department of Clinical Pharmacology, Karolinska Institute, Huddinge Hospital, Sweden.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|